On the other hand, for ESCC patients receiving radical radiotherapy with or without concurrent chemotherapy, those with high NRP1 expression had a more unfavorable PFS than those with lower NRP1 expression (p < 0.0001, Figures 5D,E). This evidence concerns the gene NRP1 and esophageal squamous cell carcinoma.